P. Willner

发表

Validation criteria for animal models of human mental disorders: Learned helplessness as a paradigm case

P. Willner, 1986, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Dopaminergic mechanism of antidepressant action in depressed patients.

P. Willner, A. Hale, S. Argyropoulos, 2005, Journal of affective disorders.

Dopamine and Depression

P. Willner, 2002 .

Depression: A Psychobiological Synthesis

P. Willner, 1985 .

The Mesolimbic Dopamine System: From Motivation to Action An International Workshop Malta September 25–29, 1989

P. Willner, J. Scheel-Krüger, J. Scheel‐Krüger, 1989, Psychobiology.

Chronic Mild Stress (CMS) Revisited: Consistency and Behavioural-Neurobiological Concordance in the Effects of CMS

P. Willner, 2005, Neuropsychobiology.

Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation

P. Willner, 1997, Psychopharmacology.

The neurobiology of depression and antidepressant action

P. Willner, J. Scheel-Krüger, C. Belzung, 2013, Neuroscience & Biobehavioral Reviews.

Further validation and development of a screening instrument for the assessment of substance misuse in adolescents.

P. Willner, 2000, Addiction.

Depression: from psychopathology to pathophysiology

P. Philippot, P. Willner, C. Belzung, 2015, Current Opinion in Neurobiology.

A cluster randomised controlled trial of a manualised cognitive behavioural anger management intervention delivered by supervised lay therapists to people with intellectual disabilities.

P. Willner, K. Hood, J. Townson, 2013, Health technology assessment.

Sleep does not cause false memories on a story-based test of suggestibility

P. Willner, M. Blagrove, E. Rijn, 2017, Consciousness and Cognition.

Resistance to antidepressant drugs: the case for a more predisposition-based and less hippocampocentric research paradigm

P. Willner, J. Scheel-Krüger, C. Belzung, 2014, Behavioural pharmacology.

Apomorphine anorexia: a further pharmacological characterization.

P. Willner, A. Towell, R. Muscat, 1986, European journal of pharmacology.

The experiences of mothers of children and young people with intellectual disabilities during the first COVID‐19 lockdown period

P. Willner, P. Langdon, J. Rose, 2021, Journal of applied research in intellectual disabilities : JARID.

The Experiences of Carers of Adults With Intellectual Disabilities During the First COVID‐19 Lockdown Period

P. Willner, P. Langdon, J. Rose, 2021, Journal of policy and practice in intellectual disabilities.

Changes in thought content following sleep deprivation in depression.

P. Willner, A. Kraft, C. Gillin, 1984, Comprehensive psychiatry.

Patterns of alcohol, cigarette and illicit drug use in English adolescents.

P. Willner, I. Sutherland, 1998, Addiction.

Fidelity of the intervention

David Cohen, Kerenza Hood, J Nuttall, 2013 .

Clarification of the memory artefact in the assessment of suggestibility.

P. Willner, 2008, Journal of intellectual disability research : JIDR.

Participants and settings

P. Willner, K. Hood, J. Townson, 2013 .

Development of a scale to measure fidelity to manualized group-based cognitive behavioural interventions for people with intellectual disabilities.

P. Willner, K. Hood, J. Townson, 2013, Research in developmental disabilities.

AN ANIMAL MODEL OF ANHEDONIA

M. Papp, P. Willner, R. Muscat, 1992, Clinical neuropharmacology.

Attention-Deficit and Disruptive Behavior Disorders

C. McDougle, D. Posey, C. Buhusi, 2014 .

Attention Deficit Hyperactivity Disorders: Animal Models

C. McDougle, D. Posey, C. Buhusi, 2014 .

The Questionnaire of Smoking Urges is sensitive to abstinence and exposure to smoking-related cues.

P. Willner, M. Morgan, G. Davies, 1999, Behavioural pharmacology.

Deprivation state but not nicotine content of the cigarette affects responding by smokers on a progressive ratio task

J. Rusted, P. Willner, A. Mackee, 1998, Psychopharmacology.

Assessment of Anger and Aggression

P. Willner, A. Jahoda, K. MacMahon, 2019, The Wiley Handbook on What Works for Offenders with Intellectual and Developmental Disabilities.

Cognitive‐Behavioral Therapy for Anxiety Disorders

P. Willner, P. Sturmey, W. Lindsay, 2012 .

The Influence of Household Substance Use on Children's Later Cigarette, Alcohol and Drug Use: A Three Factor Model.

P. Willner, I. Sutherland, 1998 .

Front & Back Matter

P. Willner, T. Kinoshita, 2012, Neuropsychobiology.

Effects of chronically administered fluoxetine and fenfluramine on food intake, body weight and the behavioural satiety sequence

P. Willner, R. Muscat, J. McGuirk, 2005, Psychopharmacology.

Fenfluramine disrupts the behavioural satiety sequence in rats

P. Willner, A. Montgomery, 2004, Psychopharmacology.

What do NHS staff learn from training on the Mental Capacity Act (2005)

P. Willner, S. Dymond, V. Price, 2013 .

stress-ind uced anhedonia

P. Willner, 2013 .

Differential effects of d-fenfluramine, l-fenfluramine and d-amphetamine on the microstructure of human eating behaviour

P. Willner, T. Silverstone, E. Goodall, 1991, Behavioural pharmacology.

Influence of Nicotine Gum on Acute Cravings for Cigarettes

P. Willner, M. Morgan, D. James, 2004, Journal of psychopharmacology.

Animal Models of Addiction

P. Willner, 1997 .

Antidepressant, anxiolytic and procognitive effects of rivastigmine and donepezil in the chronic mild stress model in rats

M. Papp, P. Willner, P. Gruca, 2016, Psychopharmacology.

Interaction of Cognitive Distortions and Cognitive Deficits in the Formulation and Treatment of Obsessive–Compulsive Behaviours in a Woman with an Intellectual Disability

P. Willner, R. Goodey, 2006 .

Effects of the 5-HT uptake inhibitors, femoxetine and paroxetine, and a 5-HT1A/B agonist, eltoprazine, on the behavioural satiety sequence

P. Willner, R. Muscat, J. McGuirk, 1992, Pharmacology Biochemistry and Behavior.

Capacity and competence: limitations on choice and action

P. Willner, 2011 .

A reappraisal of the interaction between tricyclic antidepressants and reserpine-like drugs

D. Clark, P. Willner, 1978, Psychopharmacology.

The validity of animal models of predisposition to depression.

P. Willner, P. Mitchell, 2002, Behavioural pharmacology.

The chronic mild stress (CMS) model of depression: History, evaluation and usage

P. Willner, Paul Willner, 2016, Neurobiology of Stress.

Cognitive functioning in depression: a review of theory and research

P. Willner, 1984, Psychological Medicine.

Perspectives for therapy of treatment‐resistant depression

M. Papp, P. Willner, A. Newman-Tancredi, 2021, British journal of pharmacology.

The ability of antidepressant drugs to desensitize beta-receptors is inversely correlated with their clinical potency.

P. Willner, 1984, Journal of affective disorders.

Changes in sleep architecture following chronic mild stress

P. Willner, G. Ruigt, S. Cheeta, 1997, Biological Psychiatry.

Functions of Dreaming: The Emperor'S New Clothes?

P. Willner, 2015 .

Environmental influences on behavioural sensitization to the dopamine agonist quinpirole

M. Papp, P. Willner, R. Muscat, 1992, Behavioural pharmacology.

Antidepressants and serotonergic neurotransmission: An integrative review

P. Willner, 2004, Psychopharmacology.

List of Reviewers

Natalie Armstrong, Liqiong Deng, Paul Ambrose, 2003, Journal of Cultural Economics.

Dopamine and depression: A review of recent evidence. III. The effects of antidepressant treatments

P. Willner, 1983, Brain Research Reviews.

Dopamine and depression: A review of recent evidence. I. Empirical studies

P. Willner, 1983, Brain Research Reviews.

The validity of animal models of depression

P. Willner, Paul Willner, 2004, Psychopharmacology.

Animal models of depression: an overview.

P. Willner, 1990, Pharmacology & therapeutics.

Stereospecific reversal of stress-induced anhedonia by mianserin and its (+)-enantiomer

P. Willner, C. Broekkamp, S. Cheeta, 1994, Psychopharmacology.

Excitatory Amino Acids and Their Antagonists

P. Shizgal, S. Nieuwenhuis, Sarah L Parylak, 2015 .

Noradrenergic receptor interactions in feeding elicited by stimulation of the para-ventricular hypothalamus

P. Willner, A. Towell, R. Muscat, 1989, Pharmacology Biochemistry and Behavior.

Changes in amphetamine-induced anorexia and stereotypy during chronic treatment with antidepressant drugs.

P. Willner, A. Towell, T. Montgomery, 1984, European journal of pharmacology.

Behavioural models in psychopharmacology : theoretical, industrial, and clinical perspectives

P. Willner, 1990 .

Selective Blockade of Drug-induced Place Preference Conditioning by ACPC, a Functional NDMA-receptor Antagonist

M. Papp, P. Willner, P. Gruca, 2002, Neuropsychopharmacology.

Personality: Neurobehavioural Foundation and Pharmacological Protocols

Stephanie A. Carmack, C. McDougle, D. Posey, 2014 .

Mood, cue and gender influences on motivation, craving and liking for alcohol in recreational drinkers

M. Field, P. Willner, P Willner, 1998, Behavioural pharmacology.

Optogenetic stimulation of medial prefrontal cortex excites GABAergic cells in the nucleus accumbens and hippocampus of Wistar-Kyoto rats exposed to chronic mild stress

M. Papp, P. Willner, W. Solecki, 2022, Psychopharmacology.

Insufficiency of ventral hippocampus to medial prefrontal cortex transmission explains antidepressant non-response

M. Papp, P. Willner, W. Solecki, 2021, Journal of psychopharmacology.

AMPA receptors mediate the pro-cognitive effects of electrical and optogenetic stimulation of the medial prefrontal cortex in antidepressant non-responsive Wistar–Kyoto rats

M. Papp, P. Willner, W. Solecki, 2020, Journal of psychopharmacology.

Functional lateralization in the prefrontal cortex of dopaminergic modulation of memory consolidation.

M. Papp, P. Willner, M. Niemczyk, 2019, Behavioural pharmacology.

Validation of chronic mild stress in the Wistar-Kyoto rat as an animal model of treatment-resistant depression

M. Papp, P. Willner, M. Niemczyk, 2019, Behavioural pharmacology.

The role of prefrontal cortex dopamine D2 and D3 receptors in the mechanism of action of venlafaxine and deep brain stimulation in animal models of treatment-responsive and treatment-resistant depression

M. Papp, P. Willner, M. Niemczyk, 2019, Journal of psychopharmacology.

Rapid antidepressant effects of deep brain stimulation of the pre-frontal cortex in an animal model of treatment-resistant depression

M. Papp, P. Willner, M. Niemczyk, 2018, Journal of psychopharmacology.

Effects on brain-derived neurotrophic factor signalling of chronic mild stress, chronic risperidone and acute intracranial dopamine receptor challenges

M. Papp, P. Willner, M. Niemczyk, 2018, Behavioural pharmacology.

Effect of the covid-19 pandemic on the mental health of carers of people with intellectual disabilities.

P. Willner, P. Langdon, J. Rose, 2020, Journal of applied research in intellectual disabilities : JARID.

Adapting Psychological Therapies for People with Intellectual Disabilities II

P. Willner, W. Lindsay, A. Jahoda, 2012 .

The effectiveness of psychotherapeutic interventions for people with learning disabilities: a critical overview.

P. Willner, 2005, Journal of intellectual disability research : JIDR.

The neurobiology of aggression: implications for the pharmacotherapy of aggressive challenging behaviour by people with intellectual disabilities.

P. Willner, 2015, Journal of intellectual disability research : JIDR.

From causes of aggression to interventions: The importance of context

P. Willner, C. Pert, A. Jahoda, 2013 .

Cognitive behavioural therapy for people with learning disabilities: focus on anger

P. Willner, 2007 .

CBT for People with Intellectual Disabilities

Chris Hatton, P. Willner, C. Hatton, 2006 .

Suggestibility and salience in people with intellectual disabilities: An experimental critique of the Gudjonsson Suggestibility Scale

P. Willner, Richard White, 2005 .

'It's made all of us bond since that course…' - a qualitative study of service users' experiences of a CBT anger management group intervention.

P. Willner, K. Hood, J. Townson, 2015, Journal of intellectual disability research : JIDR.

Managers’ views of the effects on their service of hosting a cognitive-behavioural anger management group

P. Willner, K. Hood, J. Townson, 2015 .

Effects of chronic mild stress on the development of drug dependence in rats

M. Papp, P. Willner, P. Gruca, 2014, Behavioural pharmacology.

CBT for People with Intellectual Disabilities: Emerging Evidence, Cognitive Ability and IQ Effects

P. Willner, W. Lindsay, John L. Taylor, 2008, Behavioural and Cognitive Psychotherapy.

The Role of Slow Changes in Catecholamine Receptor Function in The Action Of Antidepressant Drugs

P. Willner, 1990 .

Behavioural changes during withdrawal from desmethylimipramine (DMI)

P. Willner, T. Montgomery, 1981, Psychopharmacology.

Parallel changes in dopamine D2 receptor binding in limbic forebrain associated with chronic mild stress-induced anhedonia and its reversal by imipramine

M. Papp, P. Willner, V. Klimek, 1994, Psychopharmacology.

Reversal of stress-induced anhedonia by the atypical antidepressants, fluoxetine and maprotiline

M. Papp, P. Willner, R. Muscat, 2005, Psychopharmacology.

Reversal of antidepressant action by dopamine antagonists in an animal model of depression

P. Willner, R. Muscat, D. Sampson, 2005, Psychopharmacology.

Behavioural changes during withdrawal from desmethylimipramine (DMI)

P. Willner, D. Bird, T. Montgomery, 2004, Psychopharmacology.

Sensitization to the Actions of Antidepressant Drugs

P. Willner, 1989 .

Attenuation of amphetamine anorexia in rats following subchronic treatment with a tricyclic antidepressant.

P. Willner, T. Montgomery, 1980, Communications in psychopharmacology.

The mesolimbic dopamine system as a target for rapid antidepressant action

P. Willner, 1997, International clinical psychopharmacology.

Dopamine and depression: A review of recent evidence. II. Theoretical approaches

P. Willner, 1983, Brain Research Reviews.

EPILOGUE: Translational Models for the 21st Century: Reminiscence, Reflections, and Some Recommendations

P. Willner, R. Mcarthur, F. Borsini, 2008 .

A novel procedure for dissociating the anatomical bases of the behavioral effects of amphetamine

P. Willner, A. Towell, R. Muscat, 1987, Pharmacology Biochemistry and Behavior.

Treatment-resistant depression: are animal models of depression fit for purpose?

P. Willner, C. Belzung, 2015, Psychopharmacology.

Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant

P. Willner, A. Towell, A. Towell, 2004, Psychopharmacology.

Dopamine autoreceptors in the ventral tegmental area show subsensitivity following withdrawal from chronic antidepressant drug treatment

P. Willner, A. Towell, R. Muscat, 2004, Psychopharmacology.

Reliability of the chronic mild stress model of depression: A user survey

P. Willner, 2016, Neurobiology of Stress.

Optogenetic stimulation of transmission from prelimbic cortex to nucleus accumbens core overcomes resistance to venlafaxine in an animal model of treatment-resistant depression

M. Papp, P. Willner, P. Gruca, 2023, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Effects of dopamine receptor antagonists on sucrose consumption and preference

P. Willner, R. Muscat, 2004, Psychopharmacology.

Group-based cognitive–behavioural anger management for people with mild to moderate intellectual disabilities: cluster randomised controlled trial

P. Willner, K. Hood, J. Townson, 2013, British Journal of Psychiatry.

Dopaminergic mechanism of imipramine action in an animal model of depression

P. Willner, R. Muscat, D. Sampson, 1990, Biological Psychiatry.

Occupational stress, coping and wellbeing among registered psychologists working with people with intellectual disabilities during the COVID-19 pandemic in the United Kingdom

P. Willner, P. Langdon, M. Marczak, 2021, Journal of Intellectual & Developmental Disability.

The relevance of problems and models to treatment outcome: a comparative study of two agencies.

P. Willner, J. Keene, A. Love, 1999, Substance Use & Misuse.

The neuropsychology of depression

P. Willner, 1984, Behavioral and Brain Sciences.

Specific disruption of spatial behaviour in rats by central muscarinic receptor blockade

P. Willner, Tim Ellis, D. Wise, 2004, Psychopharmacology.

Motivation for alcohol assessed by multiple variable interval schedule behaviour: effects of reward size and alcohol cues.

P. Willner, S. Glautier, U. Rigney, 2001, Behavioural pharmacology.

Effect of chlordiazepoxide on the partial reinforcement extinction effect

P. Willner, R. Crowe, 1977, Pharmacology Biochemistry and Behavior.

“Depression” increases “craving” for sweet rewards in animal and human models of depression and craving

P. Willner, D. Benton, Jan Morgan, 1998, Psychopharmacology.

1.07 – Animal Models of Psychopathology: Depression, Anxiety, Schizophrenia, Substance Abuse

P. Willner, Paul Willner, 1998 .

Conditioned taste aversion and conditioned drinking: Two independent and opposing effects of 5-hydroxytryptophan?

P. Willner, R. Muscat, Tim Ellis, 2004, Psychopharmacology.

Dopaminergic mechanisms in memory consolidation and antidepressant reversal of a chronic mild stress-induced cognitive impairment`

M. Papp, P. Willner, M. Niemczyk, 2017, Psychopharmacology.

The dopamine hypothesis of schizophrenia: current status, future prospects.

P. Willner, 1997, International clinical psychopharmacology.

Readiness for Cognitive Therapy in People with Intellectual Disabilities

P. Willner, 2006 .

BTK抑制剂联合苯达莫司汀、利妥昔单抗一线治疗慢性淋巴细胞白血病/小淋巴细胞淋巴瘤的疗效及安全性

P. Shizgal, R. Bevins, L. Wilkinson, 2023, Chinese Journal of Hematology.

The effect on and experience of families with a member who has Intellectual and Developmental Disabilities of the COVID-19 pandemic in the UK: developing an investigation

P. Willner, P. Langdon, J. Rose, 2020, International journal of developmental disabilities.

Genomic Screening of Wistar and Wistar-Kyoto Rats Exposed to Chronic Mild Stress and Deep Brain Stimulation of Prefrontal Cortex

M. Papp, P. Willner, M. Kuśmider, 2019, Neuroscience.

Mediation of depression by perceptions of defeat and entrapment in high-stress mothers.

P. Willner, R. C. Goldstein, R. Goldstein, 2001, The British journal of medical psychology.

Anterior capsulectomy for contractures of the elbow.

P. Willner, 1948, The Journal of the International College of Surgeons.

A comparison of two alcohol craving questionnaires.

P. Willner, P Willner, A Love, 1998, Addiction.

Brief cognitive therapy of nightmares and post-traumatic ruminations in a man with a learning disability.

P. Willner, 2004, The British journal of clinical psychology.

A Randomized Controlled Trial of the Efficacy of a Cognitive-Behavioural Anger Management Group for Clients with Learning Disabilities

Gill Green, P. Willner, G. Green, 2002 .

Psychological Factors in Risk Assessment and Management of Inappropriate Sexual Behaviour by Men with Intellectual Disabilities

P. Willner, Mark Smith, 2004 .

The prevalence of mental health difficulties in a sample of prisoners in Trinidadian prisons referred for anger management

P. Willner, T. Bastick, G. Hutchinson, 2018, Journal of Forensic Practice.

Intellectual disability in a prison population with anger problems in Trinidad

P. Willner, T. Bastick, G. Hutchinson, 2017 .

Slipped femoral capital epiphysis: operation and results.

P. Willner, 1955, The Journal of the International College of Surgeons.

Decreased hedonic responsiveness following chronic mild stress is not secondary to loss of body weight

M. Papp, P. Willner, J. Moreau, 1996, Physiology & Behavior.

Animal models as simulations of depression.

P. Willner, 1991, Trends in pharmacological sciences.

Brief exposure to uncontrollable but not to controllable noise biases the retrieval of information from memory.

P. Willner, J. Neiva, 1986, The British journal of clinical psychology.

Effects of chronic mild stress on performance in behavioural tests relevant to anxiety and depression

P. Willner, P. D’Aquila, P. Brain, 1994, Physiology & Behavior.

CBT in a Caribbean Context: A Controlled Trial of Anger Management in Trinidadian Prisons

P. Willner, T. Bastick, G. Hutchinson, 2016, Behavioural and Cognitive Psychotherapy.

Time-, schedule-, and reinforcer-dependent effects of pimozide and amphetamine

G. Phillips, P. Willner, R. Muscat, 2005, Psychopharmacology.

Effects of amphetamine and pimozide on reinforcement and motor parameters in variable-interval performance

P. Willner, A. Towell, R. Muscat, 1987, Journal of psychopharmacology.

Magical Thinking in Obsessive-Compulsive Disorder and Generalized Anxiety Disorder

P. Willner, Bonnie West, 2011, Behavioural and Cognitive Psychotherapy.

Evaluation of executive functioning in people with intellectual disabilities.

P. Willner, S. Dymond, R. Parry, 2010, Journal of intellectual disability research : JIDR.

Behavioural genetics and its relevance to psychiatry.

D. Sanger, P. Willner, J. Bergman, 2008, Behavioural pharmacology.

Applications of behavioural pharmacology in drug discovery.

D. Sanger, P. Willner, J. Bergman, 2003, Behavioural pharmacology.

Drugs, Biochemistry, and Conscious Experience: Toward a Theory of Psychopharmacology

P. Willner, 2015, Perspectives in biology and medicine.

What does the headless cockroach remember?

P. Willner, 1978 .

Subsensitivity to rewarding and locomotor stimulant effects of a dopamine agonist following chronic mild stress

M. Papp, P. Willner, R. Muscat, 2005, Psychopharmacology.

Chronic mild stress-induced anhedonia: A realistic animal model of depression

Richard Muscat, M. Papp, P. Willner, 1992, Neuroscience & Biobehavioral Reviews.

Attenuation of place preference conditioning but not place aversion conditioning by chronic mild stress

M. Papp, P. Willner, R. Muscat, 1992, Journal of psychopharmacology.

Cholinesterase activity in the cockroach CNS does not change with training

P. Willner, J. Mellanby, 1974 .

Some observations on remote delivery of eye‐movement desensitisation and reprocessing to people with intellectual disabilities

P. Willner, G. Unwin, Gemma Rogers, 2023, Journal of Policy and Practice in Intellectual Disabilities.

Anti-anhedonic actions of the novel serotonergic agent flibanserin, a potential rapidly-acting antidepressant.

P. Willner, P. D’Aquila, P. Brain, 1997, European journal of pharmacology.

Trauma-focussed cognitive-behaviour therapy for people with mild intellectual disabilities: outcomes of a pilot study

P. Willner, R. Graham, B. Kroese, 2016 .

Effects of pimozide on sucrose consumption and preference

P. Willner, A. Towell, R. Muscat, 2004, Psychopharmacology.

Effects of imipramine on serotonergic and beta-adrenergic receptor binding in a realistic animal model of depression

M. Papp, P. Willner, V. Klimek, 1994, Psychopharmacology.

Palatable food induces an appetitive behaviour in satiated rats which can be inhibited by chronic stress

P. Willner, S. Scheggi, C. Gambarana, 1997, Behavioural pharmacology.

A view through the gateway: expectancies as a possible pathway from alcohol to cannabis.

P. Willner, Paul Willner, 2001, Addiction.

Cognitive Behavioral Therapy

P. Willner, W. Lindsay, Paul Willner, 2016 .

Central and peripheral contributions to the enhancement of amphetamine anorexia by desmethylimipramine (DMI)

P. Willner, A. Towell, D. Booth, 1985, Pharmacology Biochemistry and Behavior.

Apomorphine anorexia: the role of dopamine receptors in the ventral forebrain

P. Willner, A. Towell, R. Muscat, 2006, Psychopharmacology.

Subchronic treatment with the tricyclic antidepressant DMI increases isolation-induced fighting in rats

P. Willner, A. Theodorou, A. Montgomery, 1981, Pharmacology Biochemistry and Behavior.

Changes in mesolimbic dopamine may explain stress-induced anhedonia

P. Willner, V. Klimek, R. Muscat, 1991, Psychobiology.

The role of dopamine in rewarded behavior: ability, insight, drive or incentive?

G. Phillips, P. Willner, R. Muscat, 1991, Polish journal of pharmacology and pharmacy.

Suppression of sucrose drinking by chronic mild unpredictable stress: A methodological analysis

P. Willner, R. Muscat, 1992, Neuroscience & Biobehavioral Reviews.

Attenuation of sucrose consumption in mice by chronic mild stress and its restoration by imipramine

P. Willner, P. D’Aquila, P. Brain, 1995, Psychopharmacology.

Reversal of stress-induced anhedonia by the dopamine receptor agonist, pramipexole

P. Willner, R. Muscat, S. Cheeta, 1994, Psychopharmacology.

Animal models for Clinical Psychopharmacology: Depression, Anxiety, Schizophrenia

P. Willner, 1990 .

A matching law analysis of the effects of dopamine receptor antagonists

G. Phillips, P. Willner, R. Muscat, 1990, Psychopharmacology.

Social Influences on Individual Drug USE: Three Distinct Sub-Cultures Among Agency Non-Attenders

P. Willner, J. Keene, D. James, 1998 .

Knowledge of Mental Capacity Issues in Community Teams for Adults with Learning Disabilities

P. Willner, P. Rees, V. Griffiths, 2011 .

Antidepressant-like effects of dopamine agonists in an animal model of depression

M. Papp, P. Willner, R. Muscat, 1992, Biological Psychiatry.

Animal Models to Detect Antidepressants

M. Papp, P. Willner, 1997 .

Parametric analysis of the effects of cocaine and cocaine pretreatment on dopamine release in the nucleus accumbens measured by fast cyclic voltammetry

Z. Kruk, P. Willner, W. Wieczorek, 1995, Brain Research.

An animal model of anhedonia: attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress

Richard Muscat, M. Papp, P. Willner, 2005, Psychopharmacology.

Knowledge of mental capacity issues in residential services for people with intellectual disabilities

P. Willner, V. Price, S. Hunt, 2012 .

Different factors influence self-reports and third-party reports of anger by adults with intellectual disabilities.

P. Willner, K. Hood, J. Townson, 2013, Journal of applied research in intellectual disabilities : JARID.

Real time measurement of stimulated dopamine release in the conscious rat using fast cyclic voltammetry: dopamine release is not observed during intracranial self stimulation

Z. Kruk, P. Willner, R. Muscat, 1998, Journal of Neuroscience Methods.

A visual aid to decision-making for people with intellectual disabilities.

Simon Dymond, P. Willner, S. Dymond, 2011, Research in developmental disabilities.

Blockade of 8-OH-DPAT-induced feeding by dopamine antagonists

P. Willner, R. Muscat, A. Montgomery, 2004, Psychopharmacology.

Assessment of Anger-Related Cognitions of People with Intellectual Disabilities.

P. Willner, J. Rose, A. Jahoda, 2016, Behavioural and cognitive psychotherapy.

ASSESSMENT OF ANGER-RELATED COGNITIONS

P. Willner, J. Rose, A. Jahoda, 2016 .

Anger management groups for adolescents: A mixed-methods study of efficacy and treatment preferences

P. Willner, L. Watts, Jenny Griffiths, 2011, Clinical child psychology and psychiatry.

Self-report measures of defeat and entrapment during a brief depressive mood induction

P. Willner, R. Goldstein, 2002 .

Subjective and behavioural evaluation of cigarette cravings

P. Willner, S. Hardman, G. Eaton, 1995, Psychopharmacology.

Reward-dependent suppression or facilitation of consummatory behaviour by raclopride

G. Phillips, P. Willner, R. Muscat, 2005, Psychopharmacology.

Effects of mood manipulation on subjective and behavioural measures of cigarette craving

P. Willner, P. Willner, C. Jones, 1996, Behavioural pharmacology.

Cognitive-behavioural therapy for heroin and cocaine use: Ecological momentary assessment of homework simplification and compliance.

D. Epstein, P. Willner, K. Preston, 2016, Psychology and psychotherapy.

Stress and Depression: Insights from Animal Models

P. Willner, 1997 .

Animal models as research tools in depression

P. Willner, 1991 .

Apomorphine anorexia: A behavioural and neuropharmacological analysis

P. Willner, A. Towell, R. Muscat, 2004, Psychopharmacology.

Performance in temporal discounting tasks by people with intellectual disabilities reveals difficulties in decision-making and impulse control.

P. Willner, S. Dymond, R. Parry, 2010, American journal on intellectual and developmental disabilities.

Loss of social status: preliminary evaluation of a novel animal model of depression

P. Willner, P. D’Aquila, P. Brain, 1995, Journal of psychopharmacology.

STRENGTHS AND LIMITATIONS OF THE CHRONIC MILD STRESS (CMS) MODEL OF DEPRESSION

P. Willner, 1999 .

Evaluation of the ability of people with intellectual disabilities to 'weigh up' information in two tests of financial reasoning.

P. Willner, S. Dymond, R. Parry, 2010, Journal of intellectual disability research : JIDR.

Animal models of depression: validity and applications.

P. Willner, 1995, Advances in biochemical psychopharmacology.

ALCOHOL SALES TO UNDERAGE ADOLESCENTS

P. Willner, 2006 .

Management of sexually inappropriate behaviours in men with learning disabilities

P. Willner, G. Green, N. Gray, 2003 .

Factors associated with criminal convictions for sexually inappropriate behaviour in men with learning disabilities

P. Willner, G. Green, N. Gray, 2002 .

Assessment of anger coping skills in individuals with intellectual disabilities.

N. Brace, P. Willner, J. Phillips, 2005, Journal of intellectual disability research : JIDR.

Attributional style and perceived stress in endogenous and reactive depression.

P. Willner, A. Orwin, M. Wilkes, 1990, Journal of affective disorders.

Adapting psychological therapies for people with intellectual disabilities I: Assessment and cognitive deficit considerations

P. Willner, W. Lindsay, John L. Taylor, 2013 .

Antidepressant, anxiolytic and procognitive effects of subacute and chronic ketamine in the chronic mild stress model of depression

M. Papp, P. Willner, P. Gruca, 2017, Behavioural pharmacology.

Methods for Assessing the Validity of Animal Models of Human Psychopathology

P. Willner, Paul Willner, 1991 .

Can attribution theory explain carers' propensity to help men with intellectual disabilities who display inappropriate sexual behaviour?

P. Willner, M. Smith, 2007, Journal of intellectual disability research : JIDR.

Suppression or facilitation of operant behaviour by raclopride dependent on concentration of sucrose reward

G. Phillips, P. Willner, R. Muscat, 2005, Psychopharmacology.

Behavioural tests of the dopamine depletion hypothesis of neuroleptic-induced response decrement

G. Phillips, P. Willner, P. Hood, 2005, Psychopharmacology.

Neurotransmitters and depression: too much, too little, too unstable - or not unstable enough?

P. Willner, T. Montgomery, 1980, Trends in Neurosciences.

Effects of chlordiazepoxide and sodium valproate in two tests of spatial behaviour

P. Willner, Kerry-Anne Birberck, 1986, Pharmacology Biochemistry and Behavior.

Voltammetric evidence that subsensitivity to reward following chronic mild stress is associated with increased release of mesolimbic dopamine

J. Stamford, Z. Kruk, P. Willner, 2005, Psychopharmacology.

Psychotherapeutic interventions in learning disability: focus on cognitive behavioural therapy and mental health

P. Willner, 2009 .

Contents Vol. 74, 2016

Swansea, T. Kinoshita, P. Willner, 2017, Neuropsychobiology.

Behavioural analysis of the anorectic effects of fluoxetine and fenfluramine

G. Phillips, P. Willner, R. Muscat, 2005, Psychopharmacology.

Models of Affective Illness: Chronic Mild Stress in the Rat

M. Papp, P. Willner, 2023, Current protocols.

Behavioural microanalysis of the role of dopamine in amphetamine anorexia

P. Willner, A. Towell, R. Muscat, 1988, Pharmacology Biochemistry and Behavior.

Microstructural analysis of the involvement of beta-receptors in amphetamine anorexia

P. Willner, A. Towell, 1982, Pharmacology Biochemistry and Behavior.

Decreased hedonic responsiveness during a brief depressive mood swing.

P. Willner, S. Healy, Paul Willner, 1994, Journal of affective disorders.

Evaluation of an adapted version of the International Trauma Questionnaire for use by people with intellectual disabilities.

P. Willner, P. Langdon, J. Bisson, 2023, The British journal of clinical psychology.

P. Willner, M. Morgan, G. Davies, 2000, Psychopharmacology.

Apomorphine anorexia: The role of dopamine cell body autoreceptors

P. Willner, A. Towell, R. Muscat, 2004, Psychopharmacology.

Diurnal Variation in the Effect of Chronic Mild Stress on Sucrose Intake and Preference

P. Willner, P. D’Aquila, Janette Newton, 1997, Physiology & Behavior.

Changes in dopamine autoreceptor sensitivity in an animal model of depression

P. Willner, A. Towell, R. Muscat, 2004, Psychopharmacology.

Cognitive‐Behavioral Therapy for Anxiety Disorders

P. Willner, P. Sturmey, W. Lindsay, 2012 .

Knowledge of Advocacy Options within Services for People with Learning Disabilities

P. Willner, Amanda S. Brown, R. Jenkins, 2011 .

What do newly appointed health staff know about the Mental Capacity Act (2005)?

P. Willner, S. Dymond, G. Lewis, 2011, Medicine, science, and the law.

Changes in dopamine receptor mRNA expression following chronic mild stress and chronic antidepressant treatment

M. Papp, P. Willner, M. Dziedzicka-Wasylewska, 1997, Behavioural pharmacology.

Tests of functional equivalence between pimozide pretreatment, extinction and free feeding

P. Willner, R. Muscat, S. Sophokleous, 2004, Psychopharmacology.

Substance misuse and psychiatric comorbidity in children and adolescents

P. Willner, J. Myles, 1999 .

Excessive alcohol consumption and dependence on amphetamine are associated with parallel increases in subjective ratings of both 'wanting' and 'liking'.

P. Willner, D. James, M. Morgan, 2005, Addiction.

Animal Models for Investigating the Symptoms of Depression and the Mechanisms of Action of Antidepressant Drugs

P. Willner, R. Muscat, 1991 .

Multiple variable interval schedule behaviour in humans: effects of ethanol, mood, and reinforcer size on responding maintained by monetary reinforcement

P. Willner, S. Glautier, J. Bankart, 1998, Behavioural pharmacology.

8-OH-DPAT-induced place preference and place aversion: effects of PCPA and dopamine antagonists

M. Papp, P. Willner, 2005, Psychopharmacology.

Sweetness-dependent facilitation of sucrose drinking by raclopride is unrelated to calorie content

G. Phillips, P. Willner, R. Muscat, 1991, Pharmacology Biochemistry and Behavior.

Animal models of depression

M. Koch, P. Willner, P. Mitchell, 2006 .

Resistance to antidepressant drugs: the case for a more predisposition-based and less hippocampocentric research paradigm

P. Willner, C. Belzung, J. Scheel‐Krüger, 2014, Behavioural pharmacology.

THE BEHAVIOURAL PHARMACOLOGY OF SCHIZOPHRENIA

D. Sanger, P. Willner, A. Young, 2000 .

Decreased reactivity to sweetness following chronic exposure to mild unpredictable stress or acute administration of pimozide

G. Phillips, P. Willner, R. Muscat, 1992, Neuroscience & Biobehavioral Reviews.

Behavioural sensitization to a dopamine agonist is associated with reversal of stress-induced anhedonia

M. Papp, P. Willner, R. Muscat, 2005, Psychopharmacology.

Social influences on morphine conditioned place preference

P. Willner, P. D’Aquila, P. Brain, 1997, Behavioural pharmacology.

Pharmacological validation of the chronic mild stress model of depression

M. Papp, P. Willner, E. Moryl, 1996, European Neuropsychopharmacology.

The development and initial validation of a questionnaire to measure craving for amphetamine.

P. Willner, D. James, G. Davies, 2004, Addiction.

Generalization of Anger‐Coping Skills from Day‐Service to Residential Settings

P. Willner, Sarah Tomlinson, 2007 .

Treatment-resistant depression: are animal models of depression fit for purpose?

P. Willner, C. Belzung, 2015, Psychopharmacology.

Anatomical substrates for neuroleptic‐induced reward attenuation and neuroleptic‐induced response decrement

G. Phillips, P. Willner, R. Muscat, 1991, Behavioural pharmacology.

Anger management for people with mild to moderate learning disabilities: Study protocol for a multi-centre cluster randomized controlled trial of a manualized intervention delivered by day-service staff

P. Willner, K. Hood, J. Townson, 2011, Trials.

Pimozide does not impair sweetness discrimination

M. Papp, G. Phillips, P. Willner, 2005, Psychopharmacology.

The behavioural pharmacology of stress.

P. Willner, B. Ellenbroek, J. Bergman, 2014, Behavioural pharmacology.

Alcohol sales to underage adolescents: an unobtrusive observational field study and evaluation of a police intervention.

P. Willner, E. Dunphy, K. Hart, 2000, Addiction.

Additive effects of chronic treatment with antidepressant drugs and intermittent treatment with a dopamine agonist

M. Papp, P. Willner, R. Muscat, 1992, European Neuropsychopharmacology.

P.2.a.004 Effects of deep brain stimulation of the medial prefrontal cortex in two animal models of treatment-resistant depression

M. Papp, P. Willner, M. Niemczyk, 2017, European Neuropsychopharmacology.

Antidepressant, anxiolytic and procognitive effects of rivastigmine and donepezil in the chronic mild stress model in rats

M. Papp, P. Willner, P. Gruca, 2016, Psychopharmacology.

Behavioural specificity of 8-OH-DPAT-induced feeding

P. Willner, R. Muscat, A. Montgomery, 2004, Psychopharmacology.

Assessment of capacity to participate in court proceedings: a selective critique and some recommendations

P. Willner, 2011 .

Symbol labelling improves advantageous decision-making on the Iowa Gambling Task in people with intellectual disabilities.

P. Willner, S. Dymond, R. Parry, 2010, Research in developmental disabilities.

New advances in the understanding and treatment of addiction.

D. Sanger, P. Willner, A. Young, 2002, Behavioural pharmacology.

Cognitive behavioural anger management intervention for people with intellectual disabilities: costs of intervention and impact on health and social care resource use.

P. Willner, K. Hood, J. Townson, 2015, Journal of intellectual disability research : JIDR.